LMD Low Molecular Weight Dextran 低分子量葡聚糖 LMD Lossless Multiple Description Coding 无损多描述编码 LMD Local Marketing District 当地的市场区 ..
基于8个网页-相关网页
The main treatment was low molecular weight heparin anticoagulation and low molecular weight dextran expansion.
低分子肝素抗凝、低分子右旋糖苷扩容为其主要的治疗手段。
In addition, the company also can produce low molecular weight dextran 1500, for the special needs of laboratories and use.
此外，公司还可以生产极低分子量右旋糖酐1500，以供实验室及特殊需要的使用。
Objective:To investigate the influence of low molecular weight dextran on pancreatic microflow in acute pancreatitis in rats and its therapeutic effect on pancreatitis.
目的：探讨低分子右旋糖酐对急性胰腺炎大鼠胰腺微区血流的影响及其对胰腺炎的治疗作用。
应用推荐